HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of Cardiology World Conference

September 15-17, 2025 | London, UK

September 15 -17, 2025 | London, UK
Cardio 2025

Correlation of homocysteine levels with lipid profile and coronary artery disease in patients with chronic kidney disease under hemodialysis - Preliminary findings

Sofra Maria, Speaker at Heart Conferences
Aretaieion University Hospital, Greece
Title : Correlation of homocysteine levels with lipid profile and coronary artery disease in patients with chronic kidney disease under hemodialysis - Preliminary findings

Abstract:

Background and Aims: Patients with end-stage chronic kidney disease (ESRD) exhibit disturbances in protein and amino acid metabolism and elevated homocysteine levels. The latter has been implicated as an independent risk factor for cardiovascular events in these patients. The aim of the present study is to correlate homocysteine levels with lipid profile and cardiovascular events in patients with ERSD.

Methods: 50 patients with ERSD on hemodialysis for > 6 months, 30 men (60%) and 20 women (40%) with a mean age 67.6 years ± 13.21 were included. The main underlying diseases were hypertensive nephrosclerosis (30%) and diabetic nephropathy (22%). Patients were divided into two groups according to the presence or absence of coronary artery disease (CAD) and based on receiving or not hypolipidemic treatment and folic acid. Serum homocysteine levels were correlated with normal laboratory values, total cholesterol, triglycerides, HDL and LDL cholesterol levels.

Results: Homocysteine levels were found elevated in 78% of patients. Over the course of a year, an upward trend of homocysteine levels was observed regarding normal values (1st measurement: 21.8%, 2nd measurement: 26.6%, 3rd measurement: 29.6%). Men appeared to have higher homocysteine levels than women, but the difference was not statistically significant (p=0.17). Homocysteine levels were found to be elevated in patients without CAD compared to those with CAD (p=0.04). A positive correlation between homocysteine levels and total cholesterol (p=0.01) and LDL (p=0.007) was observed in both CAD and non-CAD patients. In addition, homocysteine levels in patients receiving hypolipidemic treatment were higher than in patients not receiving it (p=0.04). There was no statistically significant difference in homocysteine levels between patients receiving or not receiving folic acid (p=0.94).

Conclusions: Homocysteine levels were found to be elevated in a high percentage of patients but surprisingly there was no statistically significant equivalence with CAD while the correlation with cholesterol and LDL cholesterol levels was statistically significant in both groups. Our findings are contradictory based on classical knowledge, and due to the fact that are preliminary with a relatively small number of patients, further study is necessary in order to confirm our findings.

Biography:

Dr. Maria Sofra graduated from the Medical School of the University of Crete in 2018. She is currently in the third year of her residency in Nephrology and in the second year of her PhD studies at the Medical School of the National and Kapodistrian University of Athens. Her doctoral research focuses on “The impact of troponin and homocysteine levels on the cardiovascular system of end-stage chronic kidney disease patients undergoing hemodialysis, and the association between them.” In February 2025, she obtained her Master’s degree from the Medical School of the Aristotle University of Thessaloniki. Her postgraduate thesis was titled “The Interaction Between the Immune System and Kidney Disease: A Translational and Clinical Approach.” Although she has not yet published scientific articles, she is actively involved in clinical research and aims to contribute to the scientific community through future publications.

Watsapp